Alkermes (ALKS) EBITDA Margin (2010 - 2026)
Alkermes' EBITDA Margin was 9.80% in Q2 2026, down 16.00 percentage points from 25.80% a year earlier but up 17.15 percentage points from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) EBITDA Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Alkermes' EBITDA Margin was 10.73% through Jun 30, 2026, down 16.06 percentage points year-over-year; for FY2025, it was 19.05%, down 9.79 percentage points from FY2024.
- EBITDA Margin shows a five-year change of +21.99 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 28.84% in FY2024 (-0.56 pp), 29.40% in FY2023 (+22.94 pp), 6.46% in FY2022 (-8.57 pp) and 15.03% in FY2021 (+17.97 pp).
- Quarterly EBITDA Margin has moved between -16.26% (Q3 2022) and 48.64% (Q2 2023) over five years.
- Compared with a year earlier, EBITDA Margin has declined for six straight quarters, with an average year-over-year change of -6.04 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q2 2023 (a gain of 54.09 percentage points); the worst was Q4 2023 (a drop of 25.01 percentage points).
- Per Business Quant data, ALKS's EBITDA Margin in the three quarters before Q2 2026 was -7.34% (Q1 2026), 16.11% (Q4 2025) and 24.65% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Alkermes | 6.73 Bn | 3.86 Bn | 397.90 Mn | 9.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.80% |
| Mar 31, 2026 | -7.34% |
| Dec 31, 2025 | 16.11% |
| Sep 30, 2025 | 24.65% |
| Jun 30, 2025 | 25.80% |
| Mar 31, 2025 | 6.92% |
| Dec 31, 2024 | 39.43% |
| Sep 30, 2024 | 29.55% |
| Jun 30, 2024 | 29.20% |
| Mar 31, 2024 | 14.66% |
| Dec 31, 2023 | 19.38% |
| Sep 30, 2023 | 28.31% |
| Jun 30, 2023 | 48.64% |
| Mar 31, 2023 | 2.69% |
| Dec 31, 2022 | 44.40% |
| Sep 30, 2022 | -16.26% |
| Jun 30, 2022 | -5.45% |
| Mar 31, 2022 | -2.65% |
| Dec 31, 2021 | 46.40% |
| Sep 30, 2021 | -0.09% |
API Access
Alkermes EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();